Hycroft Mining (HYMC) has had the highest return since October 23, 2025 by a mid-cap US stock, returning 552.7%.
| ASSET | % RETURN |
|---|---|
Hycroft Mining (HYMC) | 552.71% |
Alumis (ALMS) | 444.89% |
Terns Pharmaceuticals (TERN) | 344.69% |
Erasca (ERAS) | 336.84% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 236.57% |
Olema Pharmaceuticals (OLMA) | 206.56% |
PACS (PACS) | 182.93% |
Immunitybio (IBRX) | 172.15% |
Cogent Biosciences (COGT) | 146.84% |
Americas Silver (USAS) | 124.4% |
Cidara Therapeutics (CDTX) | 123.05% |
Planet Labs PBC (PL) | 113.3% |
Aris Mining (ARMN) | 104.85% |
BBVA Banco Frances SA ADR (BBAR) | 104.59% |
Aura Minerals Inc Common Shares (AUGO) | 103.65% |
New Gold (NGD) | 95.88% |
Silvercorp Metals (SVM) | 94.93% |
Victoria's Secret (VSCO) | 91.94% |
Edgewise Therapeutics (EWTX) | 91.5% |
Taseko Mines (TGB) | 88.86% |
Lemonade (LMND) | 86.87% |
Wave Life Sciences (WVE) | 86.31% |
Belite Bio Inc ADR (BLTE) | 83.64% |
Central Puerto (CEPU) | 82.98% |
10X Genomics (TXG) | 82.25% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
